Literature DB >> 8972472

Multicentric angiofollicular lymph node hyperplasia in children: a clinicopathologic study of eight patients.

B N Smir1, T C Greiner, D D Weisenburger.   

Abstract

Multicentric angiofollicular lymph node hyperplasia (MAFH) is an idiopathic systemic disorder that has been reported only rarely in children. Therefore, we reviewed the clinical and pathologic features of eight patients listed in the Angiofollicular Lymph Node Hyperplasia Registry at our institution. The ages of the patients ranged from two to 17 years (median, 10 yr), and the male-to-female ratio was 1:3. The patients presented with constitutional symptoms, multifocal lymphadenopathy, hepatomegaly, and/or splenomegaly. The laboratory findings included peripheral blood cytopenias, polyclonal hypergammaglobulinemia, and renal and hepatic dysfunction. Histologically, we observed the plasma cell variant of MAFH in five patients (62.5%) and the hyaline-vascular variant in three (37.5%). Immunohistochemical stains revealed a polyclonal plasma cell population in all cases. Two of six specimens were positive for Epstein-Barr virus by RNA in situ hybridization. A clonal immunoglobulin heavy gene rearrangement was identified in one of the five specimens studied, but this had no apparent impact on the clinical course of the disease. None of the four specimens analyzed for the presence of Kaposi's sarcoma-associated herpesvirus was positive. Most patients were stable or free of disease after treatment, which included corticosteroids in six of the eight patients. We concluded that the clinical and pathologic features of MAFH in children are similar to those of adults, but MAFH seems to have a more favorable clinical course, i.e., low morbidity and mortality, in children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972472

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

Review 1.  Castleman's disease in childhood: report of three cases and review of the literature.

Authors:  Piero Farruggia; Antonino Trizzino; Nunzia Scibetta; Giovanni Cecchetto; Patrizia Guerrieri; Emanuele S G D'Amore; Paolo D'Angelo
Journal:  Ital J Pediatr       Date:  2011-10-20       Impact factor: 2.638

Review 2.  Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic review.

Authors:  Sandrine Leroy; Despina Moshous; Olivier Cassar; Yves Reguerre; Minji Byun; Vincent Pedergnana; Danielle Canioni; Antoine Gessain; Eric Oksenhendler; Claire Fieschi; Nizar Mahlaoui; Jean-Pierre Rivière; Rose-Marie Herbigneaux; Matthias Muszlak; Jean-Pierre Arnaud; Alain Fischer; Capucine Picard; Stéphane Blanche; Sabine Plancoulaine; Jean-Laurent Casanova
Journal:  Pediatrics       Date:  2011-12-12       Impact factor: 7.124

3.  Castleman's disease associated with a cerebellar chordoid meningioma and intestinal lymphangiectasia.

Authors:  Chul Jin Jeon; Mi Jin Kim; Jong Seung Lee; Ji Hyuk Lee; Doo-Sik Kong; Hyung Jin Shin; Yeon Lim Suh; Kyoung Mee Kim; Yon Ho Choe
Journal:  Childs Nerv Syst       Date:  2010-06-22       Impact factor: 1.475

4.  Multicentric Castleman's disease in a child with subpectoral involvement.

Authors:  Polat Koşucu; Ali Ahmetoğlu; Mustafa Imamoğlu; Ali Cay; Umit Cobanoğlu; Halit Reşit Gümele
Journal:  Pediatr Radiol       Date:  2003-05-27

5.  Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population.

Authors:  Karen M Chisholm; Mark D Fleming
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

Review 6.  Treatment of Castleman's disease.

Authors:  Angela Dispenzieri; Morie A Gertz
Journal:  Curr Treat Options Oncol       Date:  2005-05

Review 7.  Multicentric Castleman's disease in two cases.

Authors:  Rajni Sharma; Rachna Seth; V Thavaraj; A Bagga; S K Kabra; A K Karak; S Atri
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 5.319

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.